Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Liver Cirrhosis

raloxifene hydrochloride has been researched along with Liver Cirrhosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achiwa, K; Goto, H; Hayashi, K; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Katano, Y; Kuzuya, T; Luo, F1
Chang, CC; Chang, T; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lee, WS1
Ando, H; Kaneko, S; Komura, T; Matsushita, E; Minato, H; Shimizu, A; Takamura, T; Zen, Y1

Other Studies

3 other study(ies) available for raloxifene hydrochloride and Liver Cirrhosis

ArticleYear
Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:9

    Topics: Alanine Transaminase; Animals; Choline Deficiency; Disease Models, Animal; Estrogen Receptor alpha; Female; Gene Expression; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Size; Ovariectomy; Raloxifene Hydrochloride; RNA, Messenger; Selective Estrogen Receptor Modulators

2015
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    European journal of pharmacology, 2017, May-05, Volume: 802

    Topics: Ammonia; Animals; Body Weight; Female; Fibrosis; Gene Expression Regulation; Hemodynamics; Hepatic Encephalopathy; Hypertension, Portal; Liver; Liver Cirrhosis; Motor Activity; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; RNA, Messenger

2017
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:9

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Glucose Intolerance; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index

2007